January 11, 2012 — HeartWare International, Inc. and Dualis MedTech GmbH, a subsidiary of AVRA Surgical, Inc., announced an agreement to develop ventricular assist devices with wireless, transcutaneous energy transfer system (TETS) technology exclusively for HeartWare. Under terms of the agreement, HeartWare will fund a TETS development program for left ventricular assist devices (LVADs), as well as receive an option to fund programs to explore developments in bi-ventricular support and first rights to future developments outside the field of TETS and ventricular assist devices.
Since mid-2011, a collaborative team of HeartWare and Dualis engineers demonstrated the feasibility of integrating Dualis' proprietary wireless energy transfer technology with the HeartWare HVAD and MVAD systems.
The Dualis wireless energy transfer system for implantable devices is designed to allow patients to safely and efficiently provide power during normal daily activities. By coupling an external "sender" coil with an implanted "receiver" coil, the TETS system is able to transfer electricity through the patient's skin, thereby eliminating the traditional power and transmitter cable utilized in ventricular assist devices today.
Additional terms of the agreement were not disclosed.
For more information: www.dualis-medtech.de, www.heartware.com